FIELD: biotechnology.
SUBSTANCE: method of evaluating the anti-inflammatory activity of a biomedical cell product based on bone marrow mesenchymal stromal cells by examining the content of cytokines in the blood, namely, tumor necrosis factor-alpha (TNF-α). The method includes determining the concentration of TNF-α in the serum of peripheral blood before and after the introduction of bone marrow MSCs against the background of aseptic inflammation.
EFFECT: invention provides quick and accurate diagnostics of the decrease in the intensity of the aseptic inflammatory process after the use of BMCP reflecting the effectiveness of the use of a particular cell product and the sufficiency of the administered dose.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMEDICAL CELL PRODUCT BASED ON MAMMALIAN MESENCHYMAL STROMAL CELLS AND HEXAPEPTIDE | 2022 |
|
RU2781968C1 |
| GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
| METHOD FOR TREATMENT OF LUNG DISEASES BY INHALATION ADMINISTRATION OF MESENCHYMAL STROMAL CELLS AND HEXAPEPTIDE | 2022 |
|
RU2770364C1 |
| METHOD FOR DETERMINING THE VIABILITY OF CELLS IN BIOMEDICAL CELL PRODUCTS IN THE PROCESS OF REGENERATION | 2021 |
|
RU2777257C1 |
| METHOD OF TREATING INFECTIOUS PERITONITIS EXPERIMENTALLY | 2014 |
|
RU2553342C1 |
| IMMUNOBIOLOGICAL AGENT TO ENHANCE CELLULAR RESPONSE AGAINST HEPATITIS C VIRUS | 2023 |
|
RU2811136C1 |
| METHOD FOR INCREASING ANGIOGENIC ACTIVITY OF STROMAL CELLS OF FATTY TISSUE | 2011 |
|
RU2531502C2 |
| STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR USE IN THERAPY | 2015 |
|
RU2714236C2 |
| METHOD FOR STIMULATING SPINAL CORD REGENERATION BY MESENCHYMAL STEM CELLS, WHICH ARE INCLUDED IN THE FIBRIN MATRIX | 2016 |
|
RU2650638C1 |
| METHOD FOR TREATING EXPERIMENTAL CHRONIC TOXIC HEPATITIS | 2005 |
|
RU2295971C1 |
